Showing results (1-10 of 115) with videos related to
Sort By:
Pageof 12
La Revue Du Praticien|September 23, 2021
[When and how to talk about living donation with a kidney failure patient ?]Paolo MalvezziCurrent Opinion in Organ Transplantation|August 11, 2022
Emerging strategies for antibody-mediated rejectionPaolo MalvezziExpert Opinion on Drug Safety|September 3, 2015
The safety of calcineurin inhibitors for kidney-transplant patientsPaolo Malvezzi, Lionel RostaingPlos Medicine|May 25, 2016
Steroid-Based Therapy and Risk of Infectious ComplicationsLionel Rostaing, Paolo MalvezziExpert Opinion on Drug Safety|May 13, 2017
New formulations of tacrolimus and prevention of acute and chronic rejections in adult kidney-transplant recipientsThomas Jouve, Lionel Rostaing, Paolo MalvezziJournal of Nephropathology|October 13, 2015
Induction by anti-thymocyte globulins in kidney transplantation: a review of the literature and current usagePaolo Malvezzi, Thomas Jouve, Lionel RostaingTransplantation|July 30, 2016
Costimulation Blockade in Kidney Transplantation: An UpdatePaolo Malvezzi, Thomas Jouve, Lionel RostaingExperimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|April 5, 2016
Use of Everolimus-based Immunosuppression to Decrease Cytomegalovirus Infection After Kidney TransplantPaolo Malvezzi, Thomas Jouve, Lionel RostaingJournal of Nephropathology|April 6, 2016
Place of mTOR inhibitors in management of BKV infection after kidney transplantationThomas Jouve, Lionel Rostaing, Paolo MalvezziExpert Opinion on Drug Safety|March 27, 2019
An update on the safety of tacrolimus in kidney transplant recipients, with a focus on tacrolimus minimizationThomas Jouve, Johan Noble, Lionel Rostaing, et al.Pageof 12